Amgen Appoints Robert A. Bradway Chairman of the Board Of Directors

Loading...
Loading...
Amgen
AMGN
today announced appointments to its Board of Directors.  Robert A. Bradway, chief executive officer, has been appointed chairman of the Board, and Vance D. Coffman, an Amgen director since 2007, has been appointed lead independent director, both effective on Jan. 1, 2013. As previously announced, Kevin W. Sharer is retiring from the Board, effective Dec. 31, 2012. "On behalf of the Board and all of Amgen, we look forward to Vance Coffman's continued contributions as the new lead independent director," said Bradway, "and we thank Kevin Sharer for his 20 years of dedicated service and his contributions to the company and the patients we serve." Robert A. Bradway Mr. Bradway, 49, has served as Amgen's Chief Executive Officer since May 2012 and was appointed to the Amgen Board of Directors in October 2011. He joined the company in 2006 as Vice President, Operations Strategy, and served as Executive Vice President and Chief Financial Officer from 2007 to 2010. Prior to joining Amgen, Mr. Bradway was a Managing Director at Morgan Stanley. Mr. Bradway holds a Bachelor of Arts degree in
See full press release
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceManagement
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...